Overcoming Resistant Personality Disorders: A Personalized Psychotherapy Approach
March 1st 2008Overcoming Resistant Personality Disorders is a provocative and well-reasoned, yet frustrating volume. In it, the authors challenge various authorities on the subject; for example, they criticize the DSM for its failure to "officially endorse an underlying set of principles that would interrelate and differentiate the categories in terms of their deeper principles" and for its current Axis II categories.
Parkinson Disease: Phenomenology and Treatment of the Most Common Psychiatric Symptoms
March 1st 2008Parkinson disease (PD) is a progressive neurodegenerative disorder that is characterized by its motor signs, including resting tremor, rigidity, bradykinesia, and postural instability. PD is more common in the elderly, and there is usually no family history of the disease.
Posttraumatic Stress Disorder: Neurobiology, Psychology, and Public Health
March 1st 2008In recent years, we have learned a great deal about posttraumatic stress disorder (PTSD) and its public health implications. From 9/11 to Katrina and the present Iraq war, PTSD has been in the forefront of health concerns and public policy.
Buddhists Meet Mind Scientists in Conference on Meditation and Depression
March 1st 2008On October 20, 2007, leading researchers in the fields of mood disorders and meditation discussed the promise-and limitations-of meditation for the prevention and treatment of major depression. Participating in a day-long symposium titled "Mindfulness, Compassion, and the Treatment of Depression" was His Holiness the Dalai Lama.
Issues in Family Services for Persons With Schizophrenia
March 1st 2008Extensive evidence supports the importance of the involvement of families in the mental health care of patients with schizophrenia and other serious mental illnesses. Family involvement is endorsed by the President's New Freedom Commission and the American Psychiatric Association Practice Guidelines on schizophrenia.
Dual-Diagnosis Patients: Slow Progress in Improving Care
March 1st 2008The therapeutic challenges presented by comorbid psychiatric and substance abuse disorders, along with strategies and initiatives to improve treatment, were the focus of a recent collection of studies and reviews in the Journal of Substance Abuse Treatment.
Psychiatric Medication Guidelines Set for Preschoolers
March 1st 2008Concern about the rising number of preschool-age children receiving atypical antipsychotics, α-agonists, or other psychotherapeutic medications recently motivated pediatric mental health professionals to develop best-practice algorithms for psycho-pharmacological treatment of young children. It also prompted some states and mental health providers to initiate medication monitoring and consultation programs.
Atypical Antipsychotics for Treatment of Schizophrenia Spectrum Disorders
March 1st 2008The number of prescriptions for antipsychotic treatment of teenagers has increased sharply in office-based medical practice. Adolescents with psychotic symptoms frequently present for clinical evaluation, and early-onset schizophrenia spectrum disorders (onset of psychotic symptoms before the age of 18 years) represent an important consideration in the differential diagnosis in these youths
Negative Symptoms in Schizophrenia: The Importance of Identification and Treatment
March 1st 2008Treatment of negative symptoms of schizophrenia -- eg, problems with motivation, social withdrawal, diminished affective responsiveness, speech, and movement -- is associated with a variety of improved functional outcomes and is a vital unmet clinical need.
In Defense of Childhood: Protecting Kids' Inner Wildness
February 1st 2008In Defense of Childhood, by Chris Mercogliano, is an elegant book about societal challenges to children's innate spontaneity and exuberance. It is based on the author's more than 3 decades of experience as teacher and, ultimately, director of the Albany (New York) Free School.
The Journey of the Locum Tenens
February 1st 2008There are no books written by, or even about, locum tenens psychiatrists. Why is that? Why is their story-the story of psychiatrists who "hold a place," participate a bit, and then move on-not shared? Is there nothing in their experience worth sharing?
Through a Glass, Darkly? A Look at Psychiatry's Future
February 1st 2008It's often said that the word "crisis" is expressed in Chinese by two characters representing "danger" and "opportunity." In truth, the Chinese word for "crisis" (weiji) is better translated as "danger" (wei) and "crucial moment" (ji).
Posttraumatic Stress Disorder in Veterans
February 1st 2008There have been nearly 1.5 million military deployments to the southwest Asian combat zone since the start of the Afghanistan operation and Iraq war in 2001 and 2003, respectively. There have been many casualties, some of which have been highly profiled, such as service members being killed in action, losing limbs, or suffering blast injuries to their brain.
Psychopharmacology in the Decade Ahead
February 1st 2008Reading crystal balls has always been difficult. Nevertheless, it may be a worthwhile exercise to stop and make some educated guesses about where the field of psychopharmacology will stand 10 years from now--knowing full well that insights and discoveries we cannot predict or anticipate now may pop up to dramatically change the course and direction of clinical psychopharmacology.
A Beginning Biology of Beliefs?
February 1st 2008The idea that there may be genetic influences on how we think about God and politics is usually greeted with disbelief, even scorn. "Ludicrous," was the intense response of a distinguished psychologist-friend upon hearing me explore this topic in a brief paper.
Developing an Effective Treatment Protocol
February 1st 2008Anxiety disorders are the most prevalent disorders among children and adolescents in both community and clinical settings. The high prevalence of anxiety disorders in children and adolescents leads to increased interest in the development and implementation of effective treatments.
Evidence Grows for Value of Antipsychotics as Antidepressant Adjuncts
February 1st 2008The FDA recently approved the use of aripiprazole (Abilify) in combination with antidepressant medication for the treatment of major depression in adults. Although a variety of agents have been used in efforts to augment the effect of antidepressants, this first approved adjunct is likely to increase this use of atypical antipsychotics.
Second Messenger Systems, Genes, Neurogenesis, and Mood Disorders
February 1st 2008For many years, research on mood disorders has focused on neurotransmitters, particularly on the monoamines (serotonin, norepinephrine, and dopamine) and their action at the neuronal junction, or synapse. Although the monoamine theory helps explain the action of tricyclics, monoamine oxidase inhibitors, and SSRIs, it fails to account for many other things.